Mechanism of Shenling Baizhu Powder on treatment of ulcerative colitis based on NLRP3 inflammatory.
10.19540/j.cnki.cjcmm.20220630.401
- Author:
Yu-Hui LIU
1
;
Zi-Ling RONG
1
;
Hong-Yang ZHU
1
;
Yu-Ting LI
1
;
Yu YOU
2
Author Information
1. Jiangxi University of Chinese Medicine Nanchang 330004, China.
2. Gastroenterology Department of the First Affiliated Hospital of Nanchang University Nanchang 330006, China.
- Publication Type:Journal Article
- Keywords:
IL-1β;
MPO;
NLRP3 inflammatory;
Shenling Baizhu Powder;
ulcerative colitis
- MeSH:
Mice;
Animals;
Colitis, Ulcerative/drug therapy*;
Dextran Sulfate/adverse effects*;
NLR Family, Pyrin Domain-Containing 3 Protein/genetics*;
Interleukin-18/genetics*;
Powders;
Colon/metabolism*;
Caspase 1;
Mesalamine/adverse effects*;
Mice, Inbred BALB C;
Disease Models, Animal;
Cytokines/metabolism*;
Water;
Colitis/pathology*
- From:
China Journal of Chinese Materia Medica
2022;47(21):5863-5871
- CountryChina
- Language:Chinese
-
Abstract:
This study deciphered the mechanism of Shenling Baizhu Powder in treatment of mouse model of ulcerative colitis(UC) via NOD-like receptor thermoprotein domain 3(NLRP3) signaling pathway. After three days of adaptive feeding, 70 SPF-grade BALB/c mice were randomized into 7 groups: normal group, model group(dextran sodium sulfate, DSS), mesalazine group(DSS + 5-aminosalicylic acid, 5-ASA), NLRP3 inhibitor group(DSS + MCC950), and high-, medium-, and low-dose Shenling Baizhu Powder groups(DSS + high-, medium-, and low-dose Shenling Baizhu Powder), with 10 mice per group. The normal group had free access to double distilled water, and the remaining groups had free access to DSS-containing water to establish the acute UC model. Intragastric administration was started at the same time as modeling for one week. During the experiment, the general mental state and disease activity of each group of mice were recorded and scored. After the experiment, colon and serum samples were collected. The pathological changes in colon tissue were observed through hematoxylin-eosin(HE) staining. Enzyme-linked immunosorbent assay(ELISA) was employed to determine the levels of interleukin-18(IL-18) and myeloperoxidase(MPO) in colon tissue and interleukin-1β(IL-1β) in serum. Immunofluorescence(IF) and immunohistochemistry(IHC) methods were employed to examine the expression of NLRP3 and IL-18 in colon tissue. Western blot was employed to measure the protein levels of NLRP3, apoptosis-associated speck-like protein(ASC), cystein-aspartate protease 1(caspase-1), and downstream inflammatory cytokines in colon tissue. Compared with the normal group, the modeling of UC increased the disease activity index(DAI), colon pathological injury score, IL-1β level in serum, and IL-18 and MPO levels in colon tissue(P<0.05, P<0.01). Furthermore, the modeling caused obvious pathological changes and up-regulated the expression of NLRP3, caspase-1, ASC, pro-IL-1β, cleaved-IL-1β, pro-IL-18, and cleaved-IL-18 in the colon(P<0.01). Compared with the model group, the administration of corresponding drugs decreased the DAI, pathological injury score, IL-1β level in serum, and IL-18 and MPO levels in colon tissue, and down-regulated the protein levels of NLRP3, caspase-1, ASC, pro-IL-1β, cleaved-IL-1β, pro-IL-18, and cleaved-IL-18 in the colon(P<0.05, P<0.01). According to the results of previous study and this study, we concluded that Shenling Baizhu Powder can alleviate the inflammatory response and intestinal damage of DSS-induced UC by regulating the expression of the proteins and inflammatory cytokines associated with NLRP3 signaling pathway.
